Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-08

Clinical Trial Update: Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2b/3 clinical trial evaluating XAF5 Ointment for steatoblepharon has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XAF5 Ointment (XAF5)

Snippet

Sponsor: Topokine Therapeutics, Inc. | Conditions: Steatoblepharon | Phase 2, Phase 3 | Status: COMPLETED